• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性纤毛运动障碍患者的健康相关生活质量和未满足的需求。

Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia.

机构信息

Dept of Paediatrics, University of Pisa, Pisa, Italy.

出版信息

Eur Respir J. 2010 Apr;35(4):787-94. doi: 10.1183/09031936.00051509. Epub 2009 Sep 24.

DOI:10.1183/09031936.00051509
PMID:19797134
Abstract

Few studies have evaluated the quality of life of patients with primary ciliary dyskinesia (PCD). We sought to determine the health impact of the disease as well as the unmet needs in a large group of patients. Questionnaires were either posted or e-mailed to known patients with PCD and published online. Questionnaires included the St George's Respiratory Questionnaire, the Medical Outcomes Study Short Form-36 and a questionnaire that we produced to obtain information on age of diagnosis, symptoms and likely PCD-specific problems of these patients. 78 subjects (96% of those invited) answered all the questionnaires. Patients were diagnosed at a mean age of 9.4 yrs. Progressive worsening of the disease was observed and adherence to physiotherapy was found to be poor, particularly in adolescents and adults. Patients with the highest treatment burden had a worse quality of life. Over time patients become progressively less interested in treating their disease and adherence to treatment modalities decreases. PCD is associated with a progressive and continuous impact on the physical and mental health of the patients. Earlier identification of the patients and better strategies aimed at improving compliance with care are urgently needed.

摘要

很少有研究评估原发性纤毛运动障碍(PCD)患者的生活质量。我们试图确定该疾病对患者健康的影响以及未满足的需求。我们向已知的 PCD 患者邮寄或通过电子邮件发送了问卷,并在网上发布。问卷包括圣乔治呼吸问卷、医疗结果研究简表-36 和我们制作的问卷,以获取有关这些患者的诊断年龄、症状和可能的 PCD 特定问题的信息。78 名受试者(邀请的 96%)回答了所有问卷。患者的平均诊断年龄为 9.4 岁。观察到疾病逐渐恶化,并且发现物理治疗的依从性很差,特别是在青少年和成年人中。治疗负担最重的患者生活质量更差。随着时间的推移,患者对治疗疾病的兴趣逐渐降低,对治疗方式的依从性也降低。PCD 会对患者的身心健康产生持续的、进行性的影响。迫切需要更早地识别患者,并制定更好的策略来提高对治疗的依从性。

相似文献

1
Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia.原发性纤毛运动障碍患者的健康相关生活质量和未满足的需求。
Eur Respir J. 2010 Apr;35(4):787-94. doi: 10.1183/09031936.00051509. Epub 2009 Sep 24.
2
Cardiopulmonary assessment in primary ciliary dyskinesia.原发性纤毛运动障碍的心肺评估。
Eur J Clin Invest. 2012 Jun;42(6):617-22. doi: 10.1111/j.1365-2362.2011.02626.x. Epub 2011 Nov 29.
3
Growing up with Primary Ciliary Dyskinesia in Bradford, UK: exploring patients experiences as a physiotherapist.在英国布拉德福德长大的原发性纤毛运动障碍:作为一名物理治疗师探索患者的体验。
Physiother Theory Pract. 2014 Apr;30(3):157-64. doi: 10.3109/09593985.2013.845863. Epub 2013 Oct 24.
4
Health-related quality of life in early breast cancer.早期乳腺癌患者的健康相关生活质量
Dan Med Bull. 2010 Sep;57(9):B4184.
5
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.患有注意力缺陷/多动障碍的儿童和青少年的健康相关生活质量。
Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844.
6
Stigmatization, physical illness and mental health in primary ciliary dyskinesia.原发性纤毛运动障碍中的污名化、身体疾病与心理健康
J Health Psychol. 2006 May;11(3):467-82. doi: 10.1177/1359105306063320.
7
Morbidity, mortality, and quality-of-life outcomes of patients requiring >or=14 days of mechanical ventilation.需要机械通气≥14天的患者的发病率、死亡率及生活质量结果
Crit Care Med. 2003 May;31(5):1373-81. doi: 10.1097/01.CCM.0000065188.87029.C3.
8
Move-PCD-a multi-center longitudinal randomized controlled superiority trial on the effect of a 6-month individualized supported physical activity (PA) program on quality of life (QoL) in children, adolescents, and adults with primary ciliary dyskinesia.Move-PCD:一项为期 6 个月的个体化支持性体力活动(PA)方案对原发性纤毛运动障碍患儿、青少年和成人生活质量(QoL)影响的多中心纵向随机对照优效性研究。
Trials. 2024 Aug 15;25(1):539. doi: 10.1186/s13063-024-08379-0.
9
Factors influencing age at diagnosis of primary ciliary dyskinesia in European children.影响欧洲儿童原发性纤毛运动障碍诊断年龄的因素。
Eur Respir J. 2010 Dec;36(6):1248-58. doi: 10.1183/09031936.00001010. Epub 2010 Jun 7.
10
Ventilation inhomogeneity in children with primary ciliary dyskinesia.原发性纤毛运动障碍患儿的通气不均。
Thorax. 2012 Jan;67(1):49-53. doi: 10.1136/thoraxjnl-2011-200726. Epub 2011 Sep 26.

引用本文的文献

1
Acute Exposure to Aerosolized Nanoplastics Modulates Redox-Linked Immune Responses in Human Airway Epithelium.急性暴露于雾化纳米塑料会调节人呼吸道上皮中与氧化还原相关的免疫反应。
Antioxidants (Basel). 2025 Mar 31;14(4):424. doi: 10.3390/antiox14040424.
2
Preparation, characterisation, and testing of reservoir-based implantable devices loaded with tizanidine and lidocaine.载有替扎尼定和利多卡因的基于储库的可植入装置的制备、表征和测试。
Drug Deliv Transl Res. 2025 Apr 15. doi: 10.1007/s13346-025-01855-3.
3
A Pilot Study of Primary Ciliary Dyskinesia: Sleep-Related Disorders and Neuropsychiatric Comorbidities.
原发性纤毛运动障碍的初步研究:睡眠相关障碍和神经精神共病
J Clin Med. 2025 Feb 18;14(4):1353. doi: 10.3390/jcm14041353.
4
Validation of Polish-Language Questionnaires for Assessing the Quality of Life of Patients with Primary Ciliary Dyskinesia (PCD-QOL).中文译文:用于评估原发性纤毛运动障碍(PCD)患者生活质量的波兰语问卷的验证。
Adv Respir Med. 2024 Jun 24;92(4):254-262. doi: 10.3390/arm92040025.
5
Multidisciplinary ecosystem to study lifecourse determinants and prevention of early-onset burdensome multimorbidity (MELD-B) - protocol for a research collaboration.多学科生态系统研究生命历程决定因素及预防早发性严重多重疾病(MELD-B)——一项研究合作方案
J Multimorb Comorb. 2023 Sep 25;13:26335565231204544. doi: 10.1177/26335565231204544. eCollection 2023 Jan-Dec.
6
Observational study of health utilities in adult primary ciliary dyskinesia patients: preliminary data on associations with molecular diagnosis, clinical phenotype and HRQOL measures.成人原发性纤毛运动障碍患者健康效用的观察性研究:与分子诊断、临床表型和健康相关生活质量测量指标关联的初步数据
Multidiscip Respir Med. 2022 Dec 20;17:881. doi: 10.4081/mrm.2022.881. eCollection 2022 Jan 12.
7
Change in treatment burden among people with multimorbidity: a follow-up survey.多发病患者治疗负担的变化:一项随访调查。
Br J Gen Pract. 2022 Oct 27;72(724):e816-e824. doi: 10.3399/BJGP.2022.0103. Print 2022 Nov.
8
Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial.采用厄多司坦和/或阿奇霉素治疗原发性纤毛运动障碍患儿和成人减少恶化(REPEAT 试验):一项多中心、双盲、双模拟、2×2 部分析因、随机对照试验的研究方案。
BMJ Open Respir Res. 2022 May;9(1). doi: 10.1136/bmjresp-2022-001236.
9
Primary ciliary dyskinesia in Volendam: Diagnostic and phenotypic features in patients with a CCDC114 mutation.原发性纤毛运动障碍在沃伦丹:CCDC114 突变患者的诊断和表型特征。
Am J Med Genet C Semin Med Genet. 2022 Mar;190(1):89-101. doi: 10.1002/ajmg.c.31968. Epub 2022 Mar 27.
10
Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.用于原发性纤毛运动障碍研究的下呼吸道临床结局指标:一项范围综述
ERJ Open Res. 2021 Nov 29;7(4). doi: 10.1183/23120541.00320-2021. eCollection 2021 Oct.